Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Stock Symbol
-
APGE on Nasdaq
There are no Buy or Sell transactions made by Fairmount Funds Management LLC since 8/21/2023
Holdings reported by Fairmount Funds Management LLC for Apogee Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2.05M |
$76.3M |
$37.26 |
Mar 28, 2024 |
By Fairmount Healthcare Fund II LP |
|
|
| Common Stock |
51.2K |
$1.91M |
$37.26 |
Mar 28, 2024 |
By Peter Harwin |
|
|
| Common Stock |
51.2K |
$1.91M |
$37.26 |
Mar 28, 2024 |
By Tomas Kiselak |
|
|
| Non-Voting Common Stock |
6.74M |
|
|
Mar 28, 2024 |
By Fairmount Healthcare Fund II LP |
Common Stock |
|
| Stock Option (Right to Buy) |
10.4K |
|
|
Jun 5, 2024 |
Direct |
Common Stock |
|
| Common Stock |
0 |
|
|
Mar 28, 2024 |
By Fairmount Healthcare Fund LP |
|
|
| Non-Voting Common Stock |
0 |
|
|
Mar 28, 2024 |
By Fairmount Healthcare Fund LP |
Common Stock |
|
Transactions reported by Fairmount Funds Management LLC for Apogee Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.